{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:50Z","timestamp":1786982750090,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Novartis Pharma AG, Basel, Switzerland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40256-017-0256-x","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T02:39:55Z","timestamp":1511491195000},"page":"205-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA"],"prefix":"10.1007","volume":"18","author":[{"given":"Thy P.","family":"Do","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpamas","family":"Seetasith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Belleli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond G.","family":"Schlienger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Corda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakkarin","family":"Burudpakdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik J.","family":"Streefkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,24]]},"reference":[{"issue":"6","key":"256_CR1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL. Epidemiology of heart failure. Circ Res. 2013;113(6):646\u201359.","journal-title":"Circ Res"},{"issue":"10","key":"256_CR2","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146\u2013603.","journal-title":"Circulation"},{"issue":"27","key":"256_CR3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"13","key":"256_CR4","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/CIR.0000000000000435","volume":"134","author":"CW Yancy","year":"2016","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the heart failure society of America. Circulation. 2016;134(13):e282\u201393.","journal-title":"Circulation"},{"key":"256_CR5","unstructured":"Sica DA, Black HR. Angioedema in heart failure: occurrence with ACE inhibitors and safety of angiotensin receptor blocker therapy. Congest Heart Fail. 2002;8(6):334\u201341, 45."},{"key":"256_CR6","doi-asserted-by":"crossref","first-page":"1476402","DOI":"10.1155\/2017\/1476402","volume":"2017","author":"ER Rasmussen","year":"2017","unstructured":"Rasmussen ER, von Buchwald C, Wadelius M, Prasad SC, Kamaleswaran S, Ajgeiy KK, et al. Assessment of 105 patients with angiotensin converting enzyme-inhibitor induced angioedema. Int J Otolaryngol. 2017;2017:1476402.","journal-title":"Int J Otolaryngol"},{"issue":"6","key":"256_CR7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/HYPERTENSIONAHA.108.110270","volume":"51","author":"DR Miller","year":"2008","unstructured":"Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51(6):1624\u201330.","journal-title":"Hypertension"},{"key":"256_CR8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","volume":"60","author":"NJ Brown","year":"1996","unstructured":"Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60:8\u201313.","journal-title":"Clin Pharmacol Ther"},{"issue":"20","key":"256_CR9","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/2013.jamainternmed.34","volume":"172","author":"S Toh","year":"2012","unstructured":"Toh S, Reichman ME, Houstoun M, Ross Southworth M, Ding X, Hernandez AF, et al. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system. Arch Intern Med. 2012;172(20):1582\u20139.","journal-title":"Arch Intern Med"},{"issue":"10","key":"256_CR10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/pds.4260","volume":"26","author":"ME Reichman","year":"2017","unstructured":"Reichman ME, Wernecke M, Graham DJ, Liao J, Yap J, Chillarige Y, et al. Antihypertensive drug associated angioedema: effect modification by race\/ethnicity. Pharmacoepidemiol Drug Saf. 2017;26(10):1190\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"256_CR11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1099-1557(199605)5:3<149::AID-PDS222>3.0.CO;2-I","volume":"5","author":"DG Burkhart","year":"1996","unstructured":"Burkhart DG, Brown NJ, Griffin MR, Ray WA, Hammerstrom T, Weiss S. Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites. Pharmacoepidemiol Drug Saf. 1996;5:149\u201354.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"14","key":"256_CR12","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","volume":"165","author":"JB Kostis","year":"2005","unstructured":"Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A, Corren J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med. 2005;165(14):1637\u201342.","journal-title":"Arch Intern Med"},{"issue":"11","key":"256_CR13","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/lary.24777","volume":"124","author":"PA Loftus","year":"2014","unstructured":"Loftus PA, Tan M, Patel G, Lin J, Helman S, Badhey A, et al. Risk factors associated with severe and recurrent angioedema: an epidemic linked to ACE-inhibitors. Laryngoscope. 2014;124(11):2502\u20137.","journal-title":"Laryngoscope"},{"issue":"3","key":"256_CR14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.amjcard.2012.03.034","volume":"110","author":"H Makani","year":"2012","unstructured":"Makani H, Messerli FH, Romero J, Wever-Pinzon O, Korniyenko A, Berrios RS, et al. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol. 2012;110(3):383\u201391.","journal-title":"Am J Cardiol"},{"key":"256_CR15","unstructured":"Hill A, Bigby JA. Databases to track use of preventive services after implementation of the affordable care act. Mathematica Policy Research. 2014. \n                        https:\/\/www.mathematica-mpr.com\/our-publications-and-findings\/publications\/databases-to-track-use-of-preventive-services-after-implementation-of-the-affordable-care-act-ib\n                        \n                    . Accessed 9 Jun 2017."},{"issue":"17","key":"256_CR16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.296.17.2105","volume":"296","author":"AS Go","year":"2006","unstructured":"Go AS, Lee WY, Yang J, Lo JC, Gurwitz JH. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006;296(17):2105\u201311.","journal-title":"JAMA"},{"issue":"1","key":"256_CR17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0735-1097(01)01700-4","volume":"39","author":"PA McCullough","year":"2002","unstructured":"McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39(1):60\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"256_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pds.2313","volume":"21","author":"JS Saczynski","year":"2012","unstructured":"Saczynski JS, Andrade SE, Harrold LR, Tjia J, Cutrona SL, Dodd KS, et al. Mini-sentinel systematic evaluation of health outcome of interest definitions for studies using administrative and claims data: heart failure. Pharmacoepidemiol Drug Saf. 2012;21:10.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"256_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2332\/allergolint.12-RAI-0493","volume":"61","author":"N Inomata","year":"2012","unstructured":"Inomata N. Recent advances in drug-induced angioedema. Allergol Int. 2012;61:545\u201357.","journal-title":"Allergol Int"},{"issue":"6","key":"256_CR20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/clpt.2011.235","volume":"90","author":"S Schneeweiss","year":"2011","unstructured":"Schneeweiss S, Gagne JJ, Glynn RJ, Ruhl M, Rassen JA. Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development. Clin Pharmacol Ther. 2011;90(6):777\u201390.","journal-title":"Clin Pharmacol Ther"},{"key":"256_CR21","unstructured":"The Henry J. Kaiser Family Foundation. Distribution of the nonelderly with Medicaid by race\/ethnicity. 2016. \n                        http:\/\/kff.org\/medicaid\/state-indicator\/distribution-by-raceethnicity-4\/\n                        \n                    . Accessed 9 Jun 2017."},{"key":"256_CR22","unstructured":"Centers for Medicare and Medicaid Services, Office of Enterprise Data and Analytics, CMS Chronic Conditions Data Warehouse. Total medicare enrollment. \n                        https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/CMSProgramStatistics\/2013\/Downloads\/MDCR_ENROLL_AB\/CPS_MDCR_ENROLL_AB_5.pdf\n                        \n                    . Accessed 16 Aug 2016."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-017-0256-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0256-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T01:56:15Z","timestamp":1526694975000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-017-0256-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,24]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1007\/s40256-017-0256-x","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,24]]}}}